Bibliometric analysis and description of research trends in the treatment of psoriasis with biologic agents in the past two decades (2004–2023)

Lignende værker

• Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE Substudy
  af: Andrew Blauvelt, et al.
  Udgivet: (2024-09-01)
• Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials
  af: Alexander Egeberg, et al.
  Udgivet: (2024-03-01)
• Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center
  af: Seung-Won Jung, et al.
  Udgivet: (2022-05-01)
• Bibliometric analysis and description of research trends on T cells in psoriasis over the past two decades (2003–2022)
  af: Junchen Li, et al.
  Udgivet: (2024-01-01)
• Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study
  af: Li Y, et al.
  Udgivet: (2022-10-01)